These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 37331987)
1. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas. Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models. Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516 [TBL] [Abstract][Full Text] [Related]
3. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Li Z; Zhao W; He B; Koh TS; Li Y; Zeng Y; Zhang Z; Zhang J; Hou Z Contrast Media Mol Imaging; 2020; 2020():8843084. PubMed ID: 33299387 [TBL] [Abstract][Full Text] [Related]
4. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status. Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status. Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095 [TBL] [Abstract][Full Text] [Related]
6. Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study. Bisdas S; Shen H; Thust S; Katsaros V; Stranjalis G; Boskos C; Brandner S; Zhang J Sci Rep; 2018 Apr; 8(1):6108. PubMed ID: 29666413 [TBL] [Abstract][Full Text] [Related]
7. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
8. Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas. Su CQ; Lu SS; Zhou MD; Shen H; Shi HB; Hong XN Clin Radiol; 2019 Feb; 74(2):154-160. PubMed ID: 30391048 [TBL] [Abstract][Full Text] [Related]
9. Role of Histogram Features on Arterial Spin Labeling Perfusion Magnetic Resonance Imaging in Identifying Isocitrate Dehydrogenase Genotypes and Glioma Malignancies. Su C; Peng C; Sun Y; Damen FC; Jiang R; Xie C; Cai K Turk Neurosurg; 2024; 34(4):578-587. PubMed ID: 38874235 [TBL] [Abstract][Full Text] [Related]
10. Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques. Kern M; Auer TA; Fehrenbach U; Tanyildizi Y; Picht T; Misch M; Wiener E Neuroradiol J; 2020 Apr; 33(2):160-168. PubMed ID: 31957551 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models. Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427 [TBL] [Abstract][Full Text] [Related]
12. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping. Gao A; Zhang H; Yan X; Wang S; Chen Q; Gao E; Qi J; Bai J; Zhang Y; Cheng J Radiology; 2022 Mar; 302(3):652-661. PubMed ID: 34874198 [TBL] [Abstract][Full Text] [Related]
13. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414 [TBL] [Abstract][Full Text] [Related]
14. Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling. Guo D; Jiang B Eur J Radiol; 2023 Mar; 160():110721. PubMed ID: 36738600 [TBL] [Abstract][Full Text] [Related]
15. Non-Invasive Estimation of Glioma Hu Y; Chen Y; Wang J; Kang JJ; Shen DD; Jia ZZ Front Oncol; 2020; 10():593102. PubMed ID: 33425744 [TBL] [Abstract][Full Text] [Related]
16. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting. Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040 [TBL] [Abstract][Full Text] [Related]
18. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI. Cindil E; Sendur HN; Cerit MN; Erdogan N; Celebi F; Dag N; Celtikci E; Inan A; Oner Y; Tali T Acad Radiol; 2022 Mar; 29 Suppl 3():S52-S62. PubMed ID: 33685792 [TBL] [Abstract][Full Text] [Related]
19. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery. Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940 [TBL] [Abstract][Full Text] [Related]
20. DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival. Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Wang MZ; Zhang H; Liang LH; Feng YN; Yang JH Acad Radiol; 2020 Dec; 27(12):e263-e271. PubMed ID: 31983532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]